3Jennette JC, Falk R J, Andrassy K. Nomenclature of systemic vasculitides : proposal of an international consensus conference [ J ]. Arthritis Rheum, 1994,37 : 187 - 192.
4Hogan SL, Cooper GS, Savitz DA, et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis : a population-based, case-control study [ J ]. Clin J Am Soc Nephrol,2007 ,2 :290 - 299.
5Zhao MH, Chen M, Gao Y, et al. Propylthiouracil-induced anti- neutrophil cytoplasmic antibody-associated vasculitis [ J ]. Kidney Int,2006,69 : 1477 - 1481.
6Watts RA, Lane SE, Mooney J, et al. Epidemiology of primary systemic vasculitis and rheumatoid vasculitis 1989--2003 [ J ]. Kidney Blood Press Res ,2005,28 : 153 - 202.
7Lohrmann C, Uhl M, Kotter E, et al. Pulmonary manifestations of Wegener granulomatosis : CT findings in 57 patients and a review of the literature [ J ]. Eur J Radiol,2005 ,53 :471 - 477.
8Damoiseaux JG, Slot MC, Vaessen M, et al. Evaluation of a new fluorescent-enzyme immunoassay for diagnosis and follow-up of ANCA-associated vasculitis [ J 1. J Clin Immunol,2005,25:202 - 208.
9Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis:a study of 126 cases [ J ]. Kidney Int ,2004,65:2145 - 2152.
10Frankel SK, Cosgrove GP, Fischer A, et al. Update in the diagnosis and management of pulmonary vasculitis [ J ]. Chest, 2006, 129 : 452 - 465.
